跳至主要内容
临床试验/2024-511478-56-00
2024-511478-56-00招募中4 期

dTap booster vaccination of health care workers (HC dTap)

Varsinais-Suomen hyvinvointialue1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年4月24日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
The percentage of study participants with PT-specific IgG antibody geometric mean concentration (GMC) ≥5 IU/mL 0-7 days pre-vaccination.

研究概览

简要总结

To study pertussis, diphtheria, and tetanus immunity in health care workers before their booster vaccination with dTap vaccine and the immunological response 4 weeks after the booster vaccination.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Working constantly with infants <12 months of age and thus requirement for dTap booster vaccination every 5 years
  • > 4 years from the previous dTap vaccination
  • Compliant with study procedures (2 visits with questionnaires, blood and MLF samples, planning to receive the dTap vaccine)

排除标准

  • Medical exempt not being able to be vaccinated (e.g. severe allergic reaction from some of the components in the vaccine)

结局指标

主要结局

The percentage of study participants with PT-specific IgG antibody geometric mean concentration (GMC) ≥5 IU/mL 0-7 days pre-vaccination.

The percentage of study participants with PT-specific IgG antibody geometric mean concentration (GMC) ≥5 IU/mL 0-7 days pre-vaccination.

次要结局

  • PT-specific IgG antibody geometric mean concentration (GMC) 28 days after vaccination.
  • The difference in FHA, PRN, and Fimbriae 2/3 IgG antibody GMCs pre- and 28 days post-vaccination.
  • Pertussis antigen-specific plasma B-cell frequencies pre- and 28 days post-vaccination measured by ELISpot.
  • Pertussis antigen-specific memory B-cell frequencies pre- and 28 days post-vaccination measured by ELISpot.
  • Pertussis antigen-specific T-cell responses determined by cytokine analysis either from pertussis antigen stimulated whole blood samples/PBMC’s and/or supernatants.
  • Assays measuring pertussis specific functional immunity include: PT neutralization; PT epitope specific antibodies; avidity; adherence inhibition; bactericidal activity; bacterial opsonization and phagocytosis undertaken on serum samples taken pre- and 28 days post-vaccination.
  • Tetanus- and diphtheria toxoid-specific IgG antibody GMC measured by ELISA pre- and 28 days post-vaccination.

研究者

发起方
Varsinais-Suomen hyvinvointialue
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Lauri Ivaska

Scientific

Varsinais-Suomen hyvinvointialue

研究点 (1)

Loading locations...

相似试验